LAUNCHPAD
Live / Applied — First extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 06 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98536018
- Mark type
- Stylized text
- Filed
- 06 May 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 040 — Treatment of materials: custom manufacturing of biopharmaceutical preparations for cell therapy
- Class 042 — Scientific and technological services: Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
Owner
- Cellares Corporation, South San Francisco, CA, US
- Cellares Corporation, South San Francisco, CA, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 1 GRANTED
- 18 Nov 2025 — SOU EXTENSION 1 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Mar 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 20 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Nov 2024 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
- 22 Nov 2024 — ASSIGNED TO LIE
- 26 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Aug 2024 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 30 Aug 2024 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED